Iteos Therapeutics Inc Net Asset Quality Index
Iteos Therapeutics Inc net asset quality index. Iteos Therapeutics Inc (ITOS) has a Net Asset Quality Index of 79.3% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $623.08 Million minus total liabilities of $129.28 Million yields net assets of $493.80 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Iteos Therapeutics Inc (ITOS) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Iteos Therapeutics Inc (2018–2024)
Net asset quality index of Iteos Therapeutics Inc from 2018 to 2024. This chart shows how Iteos Therapeutics Inc's Net Asset Quality Index has evolved across 7 annual periods from 2018 to 2024. As of June 2025, the index stands at 79.3%, representing net assets of $493.80 Million against total assets of $623.08 Million USD. Check Iteos Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Iteos Therapeutics Inc Net Asset Quality Index by Year (2018–2024)
Iteos Therapeutics Inc net asset quality index by year from 2018 to 2024. The table below presents the year-by-year Net Asset Quality Index for Iteos Therapeutics Inc from 2018 to 2024, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ITOS market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.9% | $590.29 Million | $686.98 Million | $96.68 Million | ▼ -0.2 pp |
| 2023 | 86.2% | $575.23 Million | $667.59 Million | $92.36 Million | ▼ -1.7 pp |
| 2022 | 87.9% | $663.33 Million | $754.99 Million | $91.66 Million | ▲ +25.4 pp |
| 2021 | 62.5% | $552.82 Million | $884.71 Million | $331.89 Million | ▼ -31.3 pp |
| 2020 | 93.8% | $323.20 Million | $344.56 Million | $21.36 Million | ▲ +42.8 pp |
| 2019 | 51.0% | $15.67 Million | $30.74 Million | $15.07 Million | ▼ -4.0 pp |
| 2018 | 55.0% | $15.05 Million | $27.39 Million | $12.34 Million | — |